Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Inventory (2023 - 2025)

Historic Inventory for Krystal Biotech (KRYS) over the last 3 years, with Q3 2025 value amounting to $37.6 million.

  • Krystal Biotech's Inventory rose 10252.95% to $37.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.6 million, marking a year-over-year increase of 10252.95%. This contributed to the annual value of $26.5 million for FY2024, which is 27949.89% up from last year.
  • Per Krystal Biotech's latest filing, its Inventory stood at $37.6 million for Q3 2025, which was up 10252.95% from $31.0 million recorded in Q2 2025.
  • Krystal Biotech's 5-year Inventory high stood at $37.6 million for Q3 2025, and its period low was $5.3 million during Q3 2023.
  • For the 3-year period, Krystal Biotech's Inventory averaged around $19.9 million, with its median value being $18.6 million (2024).
  • Its Inventory has fluctuated over the past 5 years, first surged by 27949.89% in 2024, then surged by 10252.95% in 2025.
  • Quarter analysis of 3 years shows Krystal Biotech's Inventory stood at $7.0 million in 2023, then surged by 279.5% to $26.5 million in 2024, then skyrocketed by 41.96% to $37.6 million in 2025.
  • Its Inventory stands at $37.6 million for Q3 2025, versus $31.0 million for Q2 2025 and $29.9 million for Q1 2025.